Be the first to meet the Fierce 15 next week

Arsalan Arif, Publisher
follow me on twitter

Next week arrives our most anticipated feature yet: The Fierce 15. Our veteran biotech news team lead by John Carroll and Ryan McBride assembled one of our best classes ever. We can't wait to share it with you.

To be the first to know:

  • Visit FierceBiotech at 9:00AM ET on Tuesday, September 6
  • Follow @FierceBiotech on twitter
  • Subscribe to FierceBiotech if you haven't already, or send the link to a colleague

And to be the first to meet a few of our winners in person, attend BioPharm America 2011 in Boston. The meeting starts in just a few short days. (Direct registeristration link here.) Several Fierce 15 CEOs will take questions from John Carroll in a unique "Fierce 15 Revealed" session on Sept. 7 at BioPharm America 2011, which is produced by EBD Group. We've long collaborated on successful projects with EBD Group serving the biotech and pharma dealmaking communities.

They also know how to throw a party. I'll be there with John and Ryan and hope to see you there too.

Thanks for being part of the Fierce community.

- Arsalan Arif, Group Publisher
Questions? Ideas? E-mail me

Suggested Articles

MicuRx nabbed $7.78 million from a nonprofit focused on antimicrobial resistance to push its third antimicrobial program into human trials.

The FDA has handed Scholar Rock a rare pediatric disease designation voucher, which can allow the biotech a speedy review of its SMA med.

The FDA has placed a phase 1/2 trial of Passage Bio’s GM1 gene therapy on clinical hold pending further assessment of the risk of its delivery device.